The table below shows QIAGEN N.V.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$654.33M
$673.55M
$459.45M
$715.26M
$639.00M
$457.81M
Capital expenditure
$201.05M
$167.17M
$149.71M
$129.22M
$189.90M
$132.79M
Investing cash flow
-$305.28M
-$249.23M
-$87.66M
-$726.76M
-$202.43M
-$443.28M
Dividends paid
$54.24M
$0.00
$0.00
-
-
QGEN operating cash flow (10-K history)
QIAGEN N.V. reported operating cash flow of $654.33M for fiscal year 2025. That is down 2.9% from $673.55M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $341.60M (FY 2016) to $654.33M. Figures come from the company's audited annual reports as filed with the SEC.
